SOPHiA GENETICS S.A. (SOPH) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $7.94 (-0.38%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 3, 2026 | Mark Massaro | BTIG | $7.00 | -11.8% |
| Aug 7, 2024 | Tejas Savant | Morgan Stanley | $5.00 | -37.0% |
| Jun 27, 2024 | Subbu Nambi | Guggenheim | $6.00 | -24.4% |
| Jan 3, 2023 | Mark Massaro | BTIG | $6.00 | -24.4% |
Top Analysts Covering SOPH
SOPH vs Sector & Market
| Metric | SOPH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 5 | 8 | 18 |
| Target Upside | +49.2% | +16187.2% | +19.5% |
| P/E Ratio | -4.32 | 3.79 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $24M | $25M | $25M | 2 |
| 2026-12-31 | $26M | $26M | $27M | 3 |
| 2027-03-31 | $24M | $24M | $25M | 3 |
| 2027-06-30 | $25M | $26M | $26M | 2 |
| 2027-09-30 | $29M | $29M | $30M | 2 |
| 2027-12-31 | $32M | $32M | $33M | 3 |
| 2028-12-31 | $137M | $139M | $141M | 2 |
| 2029-12-31 | $170M | $172M | $175M | 1 |
| 2030-12-31 | $235M | $238M | $241M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $-0.21 | $-0.20 | $-0.20 | 1 |
| 2026-12-31 | $-0.20 | $-0.19 | $-0.19 | 1 |
| 2027-03-31 | $-0.19 | $-0.19 | $-0.18 | 1 |
| 2027-06-30 | $-0.19 | $-0.19 | $-0.18 | 1 |
| 2027-09-30 | $-0.14 | $-0.14 | $-0.14 | 1 |
| 2027-12-31 | $-0.13 | $-0.13 | $-0.12 | 1 |
| 2028-12-31 | $-0.54 | $-0.47 | $-0.41 | 2 |
| 2029-12-31 | $-0.17 | $-0.17 | $-0.16 | 1 |
| 2030-12-31 | $0.42 | $0.43 | $0.44 | 1 |
Frequently Asked Questions
What is the analyst consensus for SOPH?
The consensus among 5 analysts covering SOPHiA GENETICS S.A. (SOPH) is Buy with an average price target of $11.50.
What is the highest price target for SOPH?
The highest price target for SOPH is $7.00, set by Mark Massaro at BTIG on 2026-03-03.
What is the lowest price target for SOPH?
The lowest price target for SOPH is $5.00, set by Tejas Savant at Morgan Stanley on 2024-08-07.
How many analysts cover SOPH?
5 analysts have issued ratings for SOPHiA GENETICS S.A. in the past 12 months.
Is SOPH a buy or sell right now?
Based on 5 analyst ratings, SOPH has a consensus rating of Buy (2.00/5) with a +49.2% upside to the consensus target of $11.50.
What are the earnings estimates for SOPH?
Analysts estimate SOPH will report EPS of $-0.20 for the period ending 2026-09-30, with revenue estimated at $25M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.